Quality Assurance of Pharmaceuticals - A Compendium of Guidelines and Related Materials - Volume 1
(1997; 248 pages) [French] Voir le document au format PDF
Table des matières
Ouvrir ce répertoire et afficher son contenuIntroduction
Ouvrir ce répertoire et afficher son contenu1. National drug regulation
Ouvrir ce répertoire et afficher son contenu2. Product assessment and registration
Fermer ce répertoire3. Distribution
Fermer ce répertoireQuality assurance in pharmaceutical supply systems1
Afficher le document1. Introduction and general considerations
Fermer ce répertoire2. Elements of quality assessment and assurance
Afficher le document2.1 Legal base
Afficher le document2.2 Regulatory elements
Afficher le document2.3 Technical elements
Ouvrir ce répertoire et afficher son contenu3. Pre-marketing quality assessment
Ouvrir ce répertoire et afficher son contenu4. Drug quality surveillance during marketing
Afficher le documentReferences
Ouvrir ce répertoire et afficher son contenu4. The international pharmacopoeia and related activities
Ouvrir ce répertoire et afficher son contenu5. Basic tests
Ouvrir ce répertoire et afficher son contenu6. Laboratory services
Ouvrir ce répertoire et afficher son contenu7. International trade in pharmaceuticals
Ouvrir ce répertoire et afficher son contenu8. Counterfeit products
Ouvrir ce répertoire et afficher son contenu9. Training
Afficher le documentSelected WHO publications of related interest
Afficher le documentBack cover
 
2.1 Legal base

Drug quality assessment and assurance should have an adequate legal framework forming an integral part of general drug legislation. All regulatory and technical elements of quality assessment and assurance require the provision of legal powers to undertake these activities and to prescribe norms. The enabling legislation should provide the necessary authority to develop particular regulations in connexion with quality assurance during the manufacture, importation and distribution of pharmaceutical products and, in some cases, pharmaceutical raw materials. Additional regulations governing the practice of pharmacy, which form part of health legislation, may also be relevant here.

The responsibility for the development of guides, norms, and administrative regulations may frequently be assigned to a drug control agency. Wide differences in legal approaches exist between countries according to whether the administrative structure is centralized or decentralized. It is, however, possible in the case of a decentralized system to establish legislation that permits the sharing of responsibility, and the coordination of all activities in the quality assessment of pharmaceutical supply systems.

vers la section précédente vers la section suivante
 

Dernière mise à jour: le 3 mai 2013